Latest filing published 12 Dec 2019 for AMEDISYS INC, €151k.
Filing timeline
BuySaleInsider track record
Jake L. Netterville: trading record in brief
Jake L. Netterville discloses dealings in Amedisys Inc to SEC (Form 4). Between 30 June 2016 and 10 December 2019, the trades on record add up to 11 filings.
No open-market purchase appears, only 7 sales worth €1.7M. Outside the open market, there are 4 share grants. Since January 2019: no purchases and 3 sales on the market.
The latest filing, published on 12 December 2019, reports an open-market sale of €151k in Amedisys Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jake L. Netterville
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$167.5618.1% of flowCommon StockSEC:0000899243-19-029104:0
- 1,000 shares@ US$135.6414.7% of flowCommon StockSEC:0000899243-19-023291:0
- 1,863 shares@ US$118.1723.3% of flowCommon StockSEC:0000899243-19-017247:0
- 1,297 shares0Common StockSEC:0000899243-19-016567:0
- 2,394 shares@ US$121.2822.9% of flowCommon StockSEC:0000899243-18-029406:0
- 1,000 shares@ US$126.6410.0% of flowCommon StockSEC:0000899243-18-029406:1
- 4,096 shares@ US$80.4416.8% of flowCommon StockSEC:0000899243-18-016408:0
- 1,863 shares0Common StockSEC:0000899243-18-015823:0
- 2,394 shares0Common StockSEC:0000899243-17-016134:0
- 10,000 shares@ US$60.0033.1% of flowCommon StockSEC:0000899243-17-013211:0
- 2,477 shares0Common StockSEC:0000899243-16-024470:0
11 of 11 declarations